Gene transfer into CD4+ T lymphocytes: Green fluorescent protein- engineered, encephalitogenic T cells illuminate brain autoimmune responses

Nature Medicine

Volumn 5, Issue 7, 1999, Pages 843-847

  Flügel, Alexander ^a   Willem, Michael ^b   Berkowicz, Tomasz ^a   Wekerle, Hartmut ^a  

^a MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; GENE TRANSFER; HELPER CELL; IMMUNOTHERAPY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; REVIEW;

ANIMALS; AUTOIMMUNITY; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; GENE TRANSFER TECHNIQUES; GENETIC ENGINEERING; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; LUMINESCENT PROTEINS; LYMPH NODES; LYMPHOCYTE ACTIVATION; RATS; RATS, INBRED LEW; RETROVIRIDAE; TRANSFECTION;

ANIMALIA;

EID: 0344780200     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/10567     Document Type: Review

References (31)

1. Ben-Nun, A., Wekerle, H. & Cohen, I.R. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 11, 195-199 (1981).
2. Wekerle, H., Kojima, K., Lannes-Vieira, J., Lassmann, H. & Linington, C. Animal models. Ann. Neurol. 36, S47-S53 (1994).
3. Ben-Nun, A., Wekerle, H. & Cohen, I.R. Vaccination against autoimmune encephalomyelitis using attenuated cells of a T lymphocyte line reactive against myelin basic protein. Nature 292, 60-61 (1981).
4. Vandenbark, A.A., Hashim, G. & Offner, H. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341, 541-544 (1989).
5. Kramer, R. et al. Gene transfer through the blood-nerve barrier: Nerve growth factor engineered neuritogenic T lymphocytes attenuate experimental autoimmune neuritis. Nature Med. 1, 1162-1166 (1995).
6. Waisman, A. et al. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nature Med. 2, 899-905 (1996).
7. Bauer, J., Wekerle, H. & Lassmann, H. Apoptosis in brain-specific autoimmune disease. Curr. Opin. Immunol. 7, 839-843 (1995).
8. Cormack, B.P., Valdivia, R.H. & Falkow, S. FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173, 33-38 (1996).
9. + T cell lines. Eur. J. Immunol. 22, 1193-1198 (1992).
10. Rocha, B. et al. Accumulation of bromodeoxyuridine-labeled cells in central and peripheral lymphoid organs: Minimal estimates of production and turnover rates of mature lymphocytes. Eur. J. Immunol. 20, 1697-1708 (1990).
11. H cell lines responsive to myelin basic protein. J. Neuroimmunol. 39, 151-162 (1992).
12. Ludowyk, P.A., Willenborg, D.O. & Parish, C.R. Selective localization of neuro-specific T lymphocytes in the central nervous system. J. Neuroimmunol. 37, 237-250 (1992).
13. + T cells that induce experimental allergic encephalomyelitis. J. Neuroimmunol. 40, 57-70 (1992).
14. Weinberg, A.D. et al. Target organ-specific up-regulation of the MRC OX-40 marker and selective production of Th1 lymphokine mRNA by encephalitogenic T helper cells from the spinal cord of rats with experimental autoimmune encephalomyelitis. J. Immunol. 152, 4712-4721 (1994).
15. Körner, H. et al. Unimpaired autoreactive T-cell traffic within the central nervous system during tumor necrosis factor receptor-mediated inhibition of experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 92, 11066-11070 (1995).
16. Gütgemann, I., Fahrer, A.M., Altman, J.D., Davis, M.M. & Chien, Y.-H. Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity 8, 667-673 (1998).
17. Crawford, F., Kozono, H., White, J., Marrack, P. & Kappler, J.W. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity 8, 675-682 (1998).
18. Kearney, E.R., Pape, K.A., Loh, D.Y. & Jenkins, M.K. Visualization of peptide specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1, 327-339 (1994).
19. Schönrich, G. et al. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 65, 293-304 (1991).
20. Chiocchetti, A., Tolosano, E., Hirsch, E., Silengo, L. & Altruda, F. Green fluorescent protein as a reporter of gene expression in transgenic mice. Biochim. Biophys. Acta 1352, 193-202 (1997).
21. Ebert, O. et al. Lymphocyte apoptosis: Induction by gene transfer techniques. Gene Ther. 4, 296-302 (1997).
22. Kasid, A. et al. Human gene transfer: Characterization of human tumor infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man. Proc. Natl. Acad. Sci. USA 87, 473-477 (1990).
23. Woffendin, C. et al. Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells. Proc. Natl. Acod. Sci. USA 91, 11581-11585 (1994).
24. Bunnell, B.A., Muul, L.M., Donahue, R.E., Blaese, U.M. & Morgan, R.A. High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc. Natl. Acad. Sci. USA 92, 7739-7743 (1995).
25. + T lymphocytes. Gene Ther. 3, 695-705 (1996).
26. Agarwal, M. et al. Scaffold attachment region-mediated enhancement of retroviral vector. J. Virol. 72, 3720-3728 (1998).
27. Quinn, E.R., Lum, L.G. & Trevor, K.T. T cell activation modulates retrovirus-mediated gene expression. Hum. Gene Ther. 9, 1457-1467 (1998).
28. Qin, L. et al. Promoter attenuation in gene therapy: Interferon-γ and tumor necrosis factor-α inhibit transgene expression. Hum. Gene Ther. 8, 2019-2029 (1997).
29. Pette, M. et al. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology 40, 1770-1776 (1990).
30. Miller, A.D. & Rosman, G. Improved retroviral vectors for gene transfer and expression. BioTechniques 7, 980-990 (1989).
31. Markowitz, D., Goff, S. & Bank, A. A safe packaging line for gene transfer: Separating viral genes on two different plasmids. J. Viral. 62, 1120-1124 (1988).